PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Study Evaluating Effects of Multiple-Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non-Obese and Obese Postmenopausal Women
- First Posted Date
- 2014-04-01
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 24
- Registration Number
- NCT02100553
- Locations
- 🇺🇸
SeaView Research, Inc. (Screening Office), Miami, Florida, United States
🇺🇸SeaView Research, Inc., Miami, Florida, United States
Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)
- Conditions
- Atrial Fibrillation
- Interventions
- Drug: Parenteral heparin and/or oral Vitamin K antagonist
- First Posted Date
- 2014-03-31
- Last Posted Date
- 2018-05-23
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1500
- Registration Number
- NCT02100228
- Locations
- 🇮🇹
Policlinico Universitario Campus Biomedico, Roma, Lazio, Italy
🇷🇴Brasov Emergency Clinical County Hospital, Brasov, Romania
🇷🇴Prof.Dr.George I.M. Georgescu Cardiovascular Diseases Institute, Iasi, Romania
Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2014-03-27
- Last Posted Date
- 2014-06-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 27
- Registration Number
- NCT02097329
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States
Dacomitinib (PF-00299804) Pharmacokinetics In Chinese Healthy Volunteers
- First Posted Date
- 2014-03-27
- Last Posted Date
- 2014-10-03
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 14
- Registration Number
- NCT02097433
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
- Conditions
- Arthritis, Rheumatoid
- Interventions
- First Posted Date
- 2014-03-20
- Last Posted Date
- 2021-08-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 4372
- Registration Number
- NCT02092467
- Locations
- 🇺🇸
Arthritis and Rheumatology of GA, P.C., Atlanta, Georgia, United States
🇺🇸Baylor Scott and White Research Institute / Arthritis Care and Research Center, Dallas, Texas, United States
🇺🇸UPMC Arthritis and Autoimmunity Clinic, Pittsburgh, Pennsylvania, United States
A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM)
- Conditions
- Advanced Multiple Myeloma
- Interventions
- Drug: Filanesib, KSP (Eg5) inhibitor; intravenousDrug: Filgrastim, granulocyte-colony stimulating factor (G-CSF); subcutaneous
- First Posted Date
- 2014-03-20
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 154
- Registration Number
- NCT02092922
- Locations
- 🇺🇸
Emory University, Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
🇺🇸University of California, San Francisco Medical Center, San Francisco, California, United States
Study Of Palbociclib (PD-0332991) In Renal Impairment
- First Posted Date
- 2014-03-13
- Last Posted Date
- 2018-04-30
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 31
- Registration Number
- NCT02085538
- Locations
- 🇺🇸
Orlando Clinical Research Center, Orlando, Florida, United States
🇺🇸Avail Clinical Research, LLC, DeLand, Florida, United States
🇺🇸Prism Research, Saint Paul, Minnesota, United States
PH-797804 LPS Study in Healthy Volunteers
- First Posted Date
- 2014-03-12
- Last Posted Date
- 2014-03-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 24
- Registration Number
- NCT02084485
- Locations
- 🇬🇧
Pfizer Investigational Site, Denmark Hill, London, United Kingdom
A Study To Evaluate The Effect Of Food On The Behavior Of Tofacitinib Modified Release 11 Milligram Tablets In Healthy Western And Japanese Volunteers
- First Posted Date
- 2014-03-12
- Last Posted Date
- 2018-11-30
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 24
- Registration Number
- NCT02084875
- Locations
- 🇺🇸
Glendale Adventist Medical Center, Glendale, California, United States
Relative Bioavailability For Palbociclib Formulations
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2014-03-11
- Last Posted Date
- 2014-06-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 30
- Registration Number
- NCT02083640
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States